Pharma Journalist -

Amneal Pharmaceuticals announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for EluRyng (etonogestrel/ethinyl…
Read More...

3M announced that it has entered into an agreement to sell substantially all of its drug delivery business to an affiliate of Altaris Capital Partners, LLC. Subject to closing and other…
Read More...

XBiotech Inc. announced that it has entered into a definitive agreement with Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, to sell XBiotech’s novel…
Read More...

Forendo Pharma, a clinical stage drug development company focusing on novel treatments in women's health, announces signing of a License and Collaboration Agreement with Novartis. The…
Read More...

NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, announced that it has entered into a clinical collaboration agreement with Merck, known as MSD outside of…
Read More...

Equillium Inc. a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, and…
Read More...

SMi Reports: HK Packaging Consulting GmbH to present at Pre-Filled Syringes and Injectable Drug Devices conference 2020, this January. The Pre-Filled Syringes and Injectable Drug…
Read More...

SMi Reports: Dr Samareh Lajaunias, Director at Combioxin will be speaking at SMi’s 22nd Annual Superbugs & Superdrugs Conference in London in March 2020 The 22nd Annual Superbugs…
Read More...

SMi Reports: Invitation from conference chair Lynne Ensor for Pharmaceutical Microbiology East Coast 2020 in Boston SMi’s 3rd Annual Pharmaceutical Microbiology East Coast Conference…
Read More...

Regeneron Pharmaceuticals and Sanofi announced their intent to simplify their antibody collaboration for Kevzara (sarilumab) and Praluent (alirocumab) by restructuring into a…
Read More...